127 related articles for article (PubMed ID: 2855788)
1. Active specific immunotherapy with an autologous tumor cell vaccine in patients with resected non-small cell lung cancer.
Schulof RS; Mai D; Nelson MA; Paxton HM; Cox JW; Turner ML; Mills M; Hix WR; Nochomovitz LE; Peters LC
Mol Biother; 1988; 1(1):30-6. PubMed ID: 2855788
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study.
Galligioni E; Quaia M; Merlo A; Carbone A; Spada A; Favaro D; Santarosa M; Sacco C; Talamini R
Cancer; 1996 Jun; 77(12):2560-6. PubMed ID: 8640706
[TBL] [Abstract][Full Text] [Related]
3. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
Kakimi K; Nakajima J; Wada H
Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
[TBL] [Abstract][Full Text] [Related]
4. Non-small-cell lung cancer vaccine therapy: a concise review.
O'Mahony D; Kummar S; Gutierrez ME
J Clin Oncol; 2005 Dec; 23(35):9022-8. PubMed ID: 16219932
[TBL] [Abstract][Full Text] [Related]
5. Combined-modality treatment of inoperable lung cancer (i.v. immunotherapy, chemotherapy, and radiotherapy).
Robinson E; Haim N; Segal R; Veseley Z; Mekori T
Cancer Treat Rep; 1985 Mar; 69(3):251-8. PubMed ID: 2983892
[TBL] [Abstract][Full Text] [Related]
6. Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects.
Adler A; Gillon G; Lurie H; Shaham J; Loven D; Shachter Y; Shani A; Servadio C; Stein JA
J Biol Response Mod; 1987 Dec; 6(6):610-24. PubMed ID: 3330126
[TBL] [Abstract][Full Text] [Related]
7. Cytokine immunotherapy of non-small cell lung cancer.
Dubinett SM; Kradin RL
Reg Immunol; 1993; 5(3-4):232-43. PubMed ID: 8240940
[No Abstract] [Full Text] [Related]
8. Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine.
Hoover HC; Surdyke M; Dangel RB; Peters LC; Hanna MG
Cancer Res; 1984 Apr; 44(4):1671-6. PubMed ID: 6704973
[TBL] [Abstract][Full Text] [Related]
9. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
Grant SC; Kris MG; Houghton AN; Chapman PB
Clin Cancer Res; 1999 Jun; 5(6):1319-23. PubMed ID: 10389914
[TBL] [Abstract][Full Text] [Related]
10. Autologous dendritic cell vaccines for non-small-cell lung cancer.
Hirschowitz EA; Foody T; Kryscio R; Dickson L; Sturgill J; Yannelli J
J Clin Oncol; 2004 Jul; 22(14):2808-15. PubMed ID: 15254048
[TBL] [Abstract][Full Text] [Related]
11. An open-label, prospective phase I/II study evaluating the immunogenicity and safety of a ras peptide vaccine plus GM-CSF in patients with non-small cell lung cancer.
Meyer RG; Korn S; Micke P; Becker K; Huber C; Wölfel T; Buhl R
Lung Cancer; 2007 Oct; 58(1):88-94. PubMed ID: 17599645
[TBL] [Abstract][Full Text] [Related]
12. Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy.
Little AG; DeMeester TR; Ferguson MK; Skinner DB; Hoffman PC; Skosey C; Blough RR; Golomb HM
Surgery; 1986 Oct; 100(4):621-8. PubMed ID: 3020725
[TBL] [Abstract][Full Text] [Related]
13. Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.
Ockert D; Schirrmacher V; Beck N; Stoelben E; Ahlert T; Flechtenmacher J; Hagmüller E; Buchcik R; Nagel M; Saeger HD
Clin Cancer Res; 1996 Jan; 2(1):21-8. PubMed ID: 9816085
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral Bacillus Calmette-Guérin immunotherapy prior to surgery for carcinoma of the lung: results of a prospective randomized trial.
Matthay RA; Mahler DA; Beck GJ; Loke J; Baue AE; Carter DC; Mitchell MS
Cancer Res; 1986 Nov; 46(11):5963-8. PubMed ID: 3530442
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses to Bacillus Calmette-Guérin during immunotherapy in bladder cancer patients.
Winters WD; Lamm DL
Cancer Res; 1981 Jul; 41(7):2672-6. PubMed ID: 7018669
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer.
Raez LE; Cassileth PA; Schlesselman JJ; Sridhar K; Padmanabhan S; Fisher EZ; Baldie PA; Podack ER
J Clin Oncol; 2004 Jul; 22(14):2800-7. PubMed ID: 15254047
[TBL] [Abstract][Full Text] [Related]
17. Adoptive cellular immunotherapy for non-small cell lung cancer: a pilot study.
Chan B; Lee W; Hu CX; Ng P; Li KW; Lo G; Ho G; Yeung DW; Woo D
Cytotherapy; 2003; 5(1):46-54. PubMed ID: 12745587
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
[TBL] [Abstract][Full Text] [Related]
19. A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.
Chang GC; Lan HC; Juang SH; Wu YC; Lee HC; Hung YM; Yang HY; Whang-Peng J; Liu KJ
Cancer; 2005 Feb; 103(4):763-71. PubMed ID: 15637694
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of chemotherapy in combination with cytokine-induced killer cells in patients suffering from advanced non-small cell lung cancer.
Wu C; Jiang J; Shi L; Xu N
Anticancer Res; 2008; 28(6B):3997-4002. PubMed ID: 19192663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]